Lilly Heads to Court Over Cymbalta "Brain Zap" Withdrawal Issues

Source: Bloomberg

Jun 25, 2015

Eli Lilly will face jury trials in August for claims it misled consumers about “brain zaps” and other withdrawal side effects tied to its antidepressant Cymbalta.

Lilly's attempts to have the lawsuits thrown out were unsucessful, so the drugmaker must now face jurors who will decide if Lilly "designed Cymbalta studies to under-report the risk of discontinuation symptoms,” according to Bloomberg.

Lilly is facing more than 5,000 claims saying the drugmaker downplayed blockbuster Cymbalta’s withdrawal side effects, which allegedly include electrical-shock sensations described as “brain zaps” as well as nausea, vomiting and insomnia.

Read the Bloomberg article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments